FR2403079A1 - Composition pour le traitement de cancers a base d'esters d'acide glycyrrhetinique - Google Patents

Composition pour le traitement de cancers a base d'esters d'acide glycyrrhetinique

Info

Publication number
FR2403079A1
FR2403079A1 FR7826594A FR7826594A FR2403079A1 FR 2403079 A1 FR2403079 A1 FR 2403079A1 FR 7826594 A FR7826594 A FR 7826594A FR 7826594 A FR7826594 A FR 7826594A FR 2403079 A1 FR2403079 A1 FR 2403079A1
Authority
FR
France
Prior art keywords
cancer
treatment
esterified
neoplastic
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7826594A
Other languages
English (en)
Other versions
FR2403079B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biorex Laboratories Ltd
Original Assignee
Biorex Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd
Publication of FR2403079A1 publication Critical patent/FR2403079A1/fr
Application granted granted Critical
Publication of FR2403079B1 publication Critical patent/FR2403079B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a pour objet une composition pour le traitement, le soulagement ou l'amélioration d'un cancer, caractérisée en ce qu'elle contient un composé de formule générale :
FR7826594A 1977-09-15 1978-09-15 Composition pour le traitement de cancers a base d'esters d'acide glycyrrhetinique Granted FR2403079A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3854677 1977-09-15

Publications (2)

Publication Number Publication Date
FR2403079A1 true FR2403079A1 (fr) 1979-04-13
FR2403079B1 FR2403079B1 (fr) 1983-03-25

Family

ID=10404174

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7826594A Granted FR2403079A1 (fr) 1977-09-15 1978-09-15 Composition pour le traitement de cancers a base d'esters d'acide glycyrrhetinique

Country Status (4)

Country Link
JP (1) JPS5480425A (fr)
AU (1) AU3988478A (fr)
DE (1) DE2840259A1 (fr)
FR (1) FR2403079A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0812720B2 (ja) * 1992-05-29 1996-02-07 東邦瓦斯株式会社 ガス遮断装置
EP0739627A1 (fr) * 1994-06-21 1996-10-30 Albrecht, Uwe, Dipl.-Dok. Utilisation de l'acide glycyrrhizinique et de son métabolite (l'acide gylcyrrhetinique) comme agent actif dans la préparation d'un médicament pour le traitement des maladies malignes (cancer)
JP4781624B2 (ja) * 2002-10-29 2011-09-28 株式会社ミノファーゲン製薬 Ｒａｎｔｅｓ誘導剤

Also Published As

Publication number Publication date
JPS5480425A (en) 1979-06-27
FR2403079B1 (fr) 1983-03-25
AU3988478A (en) 1980-03-20
DE2840259A1 (de) 1979-03-29

Similar Documents

Publication Publication Date Title
NO158539C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv 2,6-diaminopurinforbindelse.
NL300209I1 (nl) Benzonaftaleenderivaten, werkwijze voor de bereiding ervan en hun
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
EP0300100A1 (fr) Méthode et composés permettant de réduire les inflammations dermiques
HK1073788A1 (en) Medicament for the treatment of viral skin and tumour diseases
GB8317504D0 (en) Derivatives of 9-(2-hydroxyethoxymethyl)
NO152296C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (dl)-16-fenoksy- og 16-substituerte fenoksy-9-keto-prostatriensyre-derivater
HUT63422A (en) Process for producing triazolopyrimidine derivatives and pharmaceutical compositions comprising same
MY113803A (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as medicament or diagnostic, and medicament containing them.
ES2038074A1 (es) Nuevos derivados de benzimidazol, su preparacion y su aplicacion como medicamentos.
FI895634A0 (fi) Menetelmä uusien terapeuttisesti vaikuttavien fenyylialifatyyliaminoalkaanidifosfonihappojen valmistamiseksi
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
ATE103585T1 (de) Polyamin-derivate als antineoplastische wirkstoffe.
FR2403079A1 (fr) Composition pour le traitement de cancers a base d'esters d'acide glycyrrhetinique
ES8103071A1 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
ES431497A1 (es) Procedimiento para preparar un derivado de s-triazol (1,5- a) piridina.
PT79649A (en) Process for preparing pharmaceutical compositions for therapeutical treatment of rheumatic diseases containing oxicam derivatives and 1,2-diacylglycero-3-phosphocholine
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
KR900701278A (ko) 바이러스 감염 치료용 담즙산
GB1351535A (en) Isopropylamino pyrimidine derivatives
DE3467705D1 (en) Use of 4,5'-azo-bis-salicylic acid for the manufacture of a medicament for the treatment of inflammatory disorders in the intestine
ES477630A1 (es) Procedimiento para la obtencion de preparados farmaceuticos desintoxicados de agentes alcohilantes citostaticamente efi-caces.
DE3852526D1 (de) Neue pharmazeutische Präparate sowie neue Lactosylverbindungen und ihre Herstellung.
AU2443888A (en) Agents for treating high blood pressure and cardiac insufficiency

Legal Events

Date Code Title Description
ST Notification of lapse